A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action.
By inhibiting a certain protein, the researchers were able to reduce the signals that trigger an inflammation. The study is published in Science and was done in collaboration with the University of Texas Medical Branch, Uppsala University and Stockholm University.
“We’ve developed a new drug molecule that inhibits inflammation,” says Professor Thomas Helleday, at the Department of Oncology-Pathology, Karolinska Institutet, Sweden, who co-led the study with Dr Torkild Visnes and Dr Armando Cázares-Körner. “It acts on a protein that we believe is a general mechanism for how inflammation arises in cells.”
The discovery is the result of many years of research by Thomas Helleday’s group on how DNA is repaired by the body. One of the objectives has been to fight cancer by targeting damage to the tumour cells’ DNA. Several breakthroughs have already been reported, which have led, amongst other things, to a new treatment for congenital breast and ovarian cancer using so-called PARP inhibitors, which has been available for some years.
Trials on mice
It was when developing a new molecule for inhibiting the enzyme that repairs oxygen damage to DNA that the researchers found, to their surprise, that it also dampened inflammation. It turned out that the enzyme OGG1, apart from repairing DNA, also triggers inflammation.
The inhibitor blocks the release of inflammatory proteins, such as TNF alpha. In trials on mice with acute pulmonary disease, the researchers succeeded in dampening the inflammation.
“This discovery could give rise to a new treatment for a very serious condition,” says Professor Helleday. “We’ll now be developing our OGG1 inhibitor and examining whether it can lead to new treatments for inflammatory diseases in order to cure or relieve diseases such as sepsis, COPD and severe asthma.”
The discovery was made in collaboration with Professor Istvan Boldogh from the University of Texas Medical Branch, USA.
The repair pathway on which OGG1 operates was discovered by Tomas Lindahl at Karolinska Institutet in the 1970s, an achievement that earned him the Nobel Prize in Chemistry in 2015.
Collaboration between several universities
The study was a collaboration between Karolinska Institutet, Uppsala University and Stockholm University in Sweden and the University of Texas Medical Branch, USA.
Learn more: New inflammation inhibitor discovered
The Latest on: Anti-inflammatory drug
via Google News
The Latest on: Anti-inflammatory drug
- Researchers might’ve found a life-saving coronavirus drug that’s already available nowon November 29, 2020 at 9:04 am
The Recovery team announced it would test colchicine as a potential therapy for severe COVID-19 cases. Recovery is a massive coronavirus drug trial in the UK responsible for finding the life ...
- Gout drug Colchicine to be tested as COVID-19 treatment in UK trialon November 27, 2020 at 6:55 am
Anti-inflammatory colchicine will be tested as a possible COVID-19 treatment in one of the world's biggest trials, the study website posted on Friday, the latest effort to repurpose existing medicines ...
- Anti-inflammatory drug used to treat GOUT will be tested as a treatment for Covid-19 in Oxford trialon November 27, 2020 at 6:52 am
Anti-inflammatory treatment colchicine is being added to the ranks of the drugs used in the RECOVERY trial run by the University of Oxford.
- Gout drug tested as coronavirus treatment in large UK trialon November 27, 2020 at 6:23 am
An anti-inflammatory drug widely used to treat gout and other conditions is the latest to be added to a large-scale trial in the U.K.
- Anti-inflammatory drug Colchicine to be investigated as possible COVID-19 treatmenton November 27, 2020 at 1:35 am
Colchicine, a commonly used anti-inflammatory drug, will be investigated as a possible treatment for COVID-19 in the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial, the study website ...
- Experts clash over use of certain drugs for COVID-19on November 24, 2020 at 8:30 am
Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.
- This could be the most promising life-saving COVID-19 drug to dateon November 23, 2020 at 7:12 pm
A promising coronavirus drug called CD24Fc showed in clinical trials that it could reduce the risk of respiratory failure or death by more than 50%. Merck announced plans to purchase the COVID-19 ...
- Anti-inflammatory Therapeutics Market Size, Share & Trends Analysis Report by Region, and Segment Forecasts, 2020 - 2024on November 20, 2020 at 4:15 am
LONDON--(BUSINESS WIRE)--The anti-inflammatory therapeutics market is poised to grow by USD 30.62 billion during 2020-2024, progressing at a CAGR of over 6% during the forecast period. Worried about ...
- Health experts clash over use of certain drugs for COVID-19on November 19, 2020 at 9:54 pm
Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday, ...
via Bing News